Wells Fargo’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-133
| Closed | -$108 | – | 7803 |
|
|
2023
Q3 | $108 | Buy |
133
+1
| +0.8% | +$1 | ﹤0.01% | 6754 |
|
|
2023
Q2 | $122 | Buy |
132
+54
| +69% | +$48 | ﹤0.01% | 6829 |
|
|
2023
Q1 | $59 | Buy |
78
+3
| +4% | +$6 | ﹤0.01% | 7066 |
|
|
2022
Q4 | $188 | Buy |
75
+5
| +7% | +$9 | ﹤0.01% | 6636 |
|
|
2022
Q3 | $0 | Buy |
70
+2
| +3% | +$3 | ﹤0.01% | 7685 |
|
|
2022
Q2 | $0 | Buy |
68
+10
| +17% | +$21 | ﹤0.01% | 7789 |
|
|
2022
Q1 | $0 | Hold |
58
| – | – | ﹤0.01% | 8122 |
|
|
2021
Q4 | $0 | Hold |
58
| – | – | ﹤0.01% | 8057 |
|
|
2021
Q3 | $0 | Buy |
58
+14
| +32% | +$36 | ﹤0.01% | 7732 |
|
|
2021
Q2 | $0 | Sell |
44
-1
| -2% | -$3 | ﹤0.01% | 7666 |
|
|
2021
Q1 | $0 | Buy |
45
+16
| +55% | +$54 | ﹤0.01% | 7581 |
|
|
2020
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 7223 |
|
|
2020
Q3 | $0 | Sell |
29
-86
| -75% | -$278 | ﹤0.01% | 7111 |
|
|
2020
Q2 | $0 | Sell |
115
-10,394
| -99% | -$29.3K | ﹤0.01% | 7008 |
|
|
2020
Q1 | $21K | Buy |
10,509
+10,074
| +2,316% | +$36.9K | ﹤0.01% | 5594 |
|
|
2019
Q4 | $2K | Buy |
435
+3
| +0.7% | +$10 | ﹤0.01% | 6201 |
|
|
2019
Q3 | $1K | Buy |
432
+392
| +980% | +$1.15K | ﹤0.01% | 6317 |
|
|
2019
Q2 | $0 | Buy |
40
+39
| +3,900% | +$743 | ﹤0.01% | 6697 |
|
|
2019
Q1 | $0 | Sell |
1
-1,799
| -100% | -$42.5K | ﹤0.01% | 6566 |
|
|
2018
Q4 | $36K | Sell |
1,800
-3,432
| -66% | -$79K | ﹤0.01% | 5631 |
|
|
2018
Q3 | $162K | Buy |
5,232
+470
| +10% | +$12.6K | ﹤0.01% | 5121 |
|
|
2018
Q2 | $102K | Sell |
4,762
-1,595
| -25% | -$30.3K | ﹤0.01% | 5370 |
|
|
2018
Q1 | $123K | Buy |
6,357
+652
| +11% | +$11.9K | ﹤0.01% | 5222 |
|
|
2017
Q4 | $79K | Buy |
+5,705
| New | +$92.9K | ﹤0.01% | 5400 |
|
|
2017
Q1 | – | Sell |
-180
| Closed | -$2K | – | 6572 |
|
|
2016
Q4 | $2K | Buy |
+180
| New | +$3.15K | ﹤0.01% | 6114 |
|
|
2014
Q3 | – | Sell |
-97
| Closed | -$13K | – | 6392 |
|
|
2014
Q2 | $13K | Sell |
97
-85
| -47% | -$11.3K | ﹤0.01% | 5550 |
|
|
2014
Q1 | $28K | Sell |
182
-191
| -51% | -$29K | ﹤0.01% | 5127 |
|
|
2013
Q4 | $57K | Buy |
+373
| New | +$60.7K | ﹤0.01% | 4707 |
|
Other funds holding ACER
Wells Fargo's ACER Position: Q4 2023 in Review
Wells Fargo sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 133 shares — an estimated $108 sold.
Wells Fargo first reported a position in ACER in Q4 2013 and held it in 28 quarters. The position peaked at $162K in Q3 2018. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- Wells Fargo reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- Wells Fargo sold 133 Acer Therapeutics Inc shares in Q4 2023, an estimated $108.
- Wells Fargo first reported a position in Acer Therapeutics Inc in Q4 2013 and held it in 28 quarters.
- Wells Fargo's Acer Therapeutics Inc position peaked at $162K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.